跳至主要内容
临床试验/IRCT20200628047940N3
IRCT20200628047940N3招募中3 期

The effect of probiotics consumption on liver function in Primary Sclerosing Cholangitis patients: A double-blinded randomized clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients with a definitive diagnosis of primary sclerosing cholangitis(PSC)
  • Patients' informed consent to participate in the study

排除标准

  • Neurological disease
  • Chronic alcoholic fatty liver
  • Chronic hepatitis B, C
  • Wilson disease
  • Hemochromatosis disease
  • Secondary sclerosing cholangitis
  • Primary cirrhosis of the bile ducts
  • Benign or malignant tumor of the liver or bile ducts
  • Peritonitis
  • Variceal bleeding
  • Inflammation of the brain caused by hepatitis in the past 2 months
  • Consumption of probiotics, prebiotics, synbiotics or antibiotics 4 weeks before the start of the study
  • High protein diet
  • Active microbial infection
  • Autoimmune disease or the use of immunosuppressive drugs
  • Probability of liver transplantation in the next year based on secondary sclerosing cholangitis risk score Mayo
  • Alpha antitrypsin deficiency
  • Consumption of ursodeoxycholic acid
  • Consumption of alcohol or drugs
  • Pregnancy and lactation

研究者

相似试验

The effect of probiotics consumption on liver functio | 临床试验